Oncolys BioPharma Inc.

$14.11

$0.90(-5.99%)

Oncolys BioPharma Inc.

4588.T

$14.11

$0.90(-5.99%)

Oncolys BioPharma Inc.

4588.T

JPX

$14.11

$0.90(-5.99%)

Chart

Upcoming Earnings

Next report date

May 8, 2026

Report period

Q2 2026

EPS Estimate

—

Revenue Estimate

—

Key stats

52-Week Range$14.11

$2.87

$21.37

Market capitalization

$426.16M

Dividend yield (indicated)

0.00%

Price to earnings Ratio (TTM)

-40.44

Basic EPS (TTM)

$-0.51

Net income (TTM)

$-12.88M

Revenue (TTM)

$178.62K

Avg. volume

2.91M

Beta (1Y)

0.91

Employees

Market capitalization

$426.16M

Dividend yield (indicated)

0.00%

Price to earnings Ratio (TTM)

-40.44

Basic EPS (TTM)

$-0.51

Net income (TTM)

$-12.88M

Revenue (TTM)

$178.62K

Avg. volume

2.91M

Beta (1Y)

0.91

Employees

Screener Quick Check

About Oncolys BioPharma Inc.

Sector

Healthcare

Industry

Biotechnology

CEO

Yasuo Urata

Website

www.oncolys.com

Headquarters

Toranomon Towers Office, Tokyo, 105-0001

IPO Date

2013-12-06

Identifiers

ISINJP3202170001

Description

Oncolys BioPharma Inc. engages in the research, development, manufacture, sale, import, and export of oncolytic viruses,...

Related Stocks

Japan Tissue Engineering Co., Ltd.

7774.T

$3.37Mkt Cap: $136.71M

Healthcare

Biotechnology

ISIN:JP3389610001

RaQualia Pharma Inc.

4579.T

$5.44Mkt Cap: $133.00M

Healthcare

Biotechnology

ISIN:JP3967150008

Dividend Overview

This company does not pay dividends

Financials

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate